Canadian public market financing starts 2017 on a very positive note. The public market has been gradually improving from the low of $20.5 billion recorded in Q3 2016, following the peak of $35.6 billion in Q2 2016.
Canadian public companies raised $30.81 billion in 599 deals in Q1 2017, up 46% and 96% in dollar raised and number of deals respectively from the same period last year, up 14% in dollar value but down 1% in deal numbers from previous period in Q4 2016.
In 2016, $104.31 billion in 2240 deals were completed by Canadian public companies.
Largely driven by Valeant’s US $6.25 billion financing, debt offering raised $19.05 billion in 29 deals in Q1 2017, accounting for 61.8% of the total dollar raised but only 4.8% of the total number of deals.
Excluding the large Valeant deal, debt offering has been consistent accounting for 44-49% of total dollar raised since 2016.
Next: Biotech/Life Sciences, Oil & Gas, Mining led public financing in Q1 2017.
We are Canada’s only data provider that specifically tracks and provides metrics on venture capital investments by investor type, by source of funding, and fundraising activities.
We provide trusted, unbiased (without undue industry influence), and verified private and public market news and intelligence to all industry stakeholders